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Primary cutaneous B cell lymphomas are de®ned as
non-Hodgkin lymphomas that occur in the skin
without extracutaneous involvement for 6 mo after
diagnosis. They are characterized by a less aggressive
course and better prognosis than their nodal counter-
parts. According to the European Organization for
Research and Treatment of Cancer classi®cation, the
major subentities of primary cutaneous B cell lym-
phoma are follicle center cell lymphomas, immuno-
cytomas, and large B cell lymphomas of the leg,
which differ considerably regarding their clinical
behavior, the former two being indolent, the latter
being of intermediate malignancy. In this study, we
applied a single cell polymerase chain reaction
approach to analyze immunoglobulin VH/VL genes
in 532 individual B lymphocytes from histologic sec-
tions of four follicle center cell lymphomas localized
on the head and trunk, and four large B cell lympho-
mas on the leg. We found: (i) in six of eight patients
a clonal heavy chain, and in seven of eight patients a
clonal light chain rearrangement, all being poten-
tially productive; (ii) no bias in VH gene usage, in
four of seven light chain rearrangements the Vk
germline gene IGVK3-20*1 was used; (iii) no biallelic
rearrangements; (iv) all VH/VL genes are extensively
mutated (mutation rate 5.4±16.3%); (v) intraclonal
diversity in six of eight cases (three of each group);
and (vi) low replacement vs silent mutation ratios in
framework regions indicating preservation of anti-
gen-receptor structure, as in normal B cells selected
for antibody expression. Our data indicate a germ-
inal center cell origin of primary cutaneous follicle
center cell lymphomas and large B cell lymphomas
independent of those belonging to one of these
subentities. Key words: immunoglobulin heavy chain
rearrangement/immunoglobulin light chain rearrangement/
somatic mutation/CBCL/B-lymphocytes. J Invest Dermatol
117:1512±1520, 2001
P
rimary cutaneous B cell lymphomas (PCBCL) occur in
the skin without evidence of internal involvement for a
period of at least 6 mo after diagnosis (Burg et al, 1977;
Kerl and Burg, 1979). Although histologic parameters
are comparable, the primary cutaneous lymphomas
differ from their nodal counterparts in a more indolent clinical
behavior resulting in a more favorable prognosis, and in a better
response to less aggressive treatment strategies (Willemze et al,
1997). The group of cutaneous B cell lymphomas is heterogeneous
in itself. The lesions of large B cell lymphomas appearing initially
on the lower leg in elderly patients contain a higher proportion of
large bcl-2 positive centroblasts and less in®ltrating reactive T cells.
This subentity is characterized by a more aggressive clinical course
in comparison with follicle center cell lymphomas localized in head
and trunk areas (Vermeer et al, 1996; Geelen et al, 1998; Bekkenk et
al, 1999). The latter represent another type of PCBCL histologi-
cally characterized by nodular or diffuse in®ltrates consisting of
variable proportions of centrocytes, a few centroblasts, and many
reactive T cells (Willemze et al, 1997).
During ontogeny, the B cell's antigen receptor is subject to
multiple alterations. Naive B cells carry surface immunoglobulins
encoded by unmutated, germline-identical immunoglobulin genes
(Hummel et al, 1994). In response to antigen presentation by
follicular dendritic cells within the germinal centers, B cells
proliferate. As recognition of antigen provides signals for growth
and T cell help, those B cells become selected to produce
antibodies, which have the highest af®nity to bind this antigen
(Lindhout et al, 1997). The maturation of af®nity is based on amino
acid replacements within the antigen binding regions of the
immunoglobulin molecule (Berek et al, 1991; Jacob et al, 1991)
introduced in the process of somatic hypermutation during
proliferation inside the germinal centers (for review see
Rajewsky, 1996). Therefore, conclusions can be drawn from the
mutational pattern of immunoglobulin genes in a B cell clone
concerning the maturational state of B lymphocytes and the
descending lymphomas. When tumors descend from germinal
center B cells, the VH/VL genes show a characteristic mutational
pattern. As the process of somatic hypermutation is still under way,
analysis of the individual VH/VL genes shows a certain degree of
intraclonal diversity (Bahler and Levy, 1992; Stamatopoulos et al,
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2000). Somatically mutated variable region genes in the absence
of intraclonal diversity (i.e., the mutational process has stopped)
is typical for postgerminal center B cells and the descending
tumors.
Accordingly, previous studies could ascribe mantle cell lympho-
mas (Hummel et al, 1994) to a pregerminal center cell origin
because of the predominance of unmutated immunoglobulin genes,
whereas other NHL entities (for review see MuÈller-Hermelink and
Greiner, 1998; KuÈppers et al, 1999; Spencer and Dunn-Walters,
1999) expressing mutated immunoglobulin genes represent the
expansion of germinal center cells, as in follicle center cell
lymphomas (Bahler and Levy, 1992; Zhu et al, 1994), or of
postgerminal center cells as it is the case in multiple myelomas
(Bakkus et al, 1992) and monocytoid B cell lymphomas (KuÈppers et
al, 1996). Recent data by Aarts et al (1998), for PCBCL indicate a
germinal center cell origin of these skin-located neoplasias.
Until recently, different molecular biologic techniques were used
to study the immunoglobulin gene expression in malignant B cells,
such as mRNA libraries (Aarts et al, 1998), genomic gene libraries
(Hammer et al, 1993), and microdissection techniques followed by
polymerase chain reaction (PCR) of genomic bulk DNA and
hybridization techniques (Cerroni et al, 2000). All these techniques
have disadvantages due to arti®cial immunoglobulin gene combin-
ation, PCR errors, or low hybridization probe speci®city. Such
problems can be overcome by applying a single cell approach
(Ehlich and KuÈppers, 1995; KuÈppers et al, 1997), consisting of
micromanipulation and single cell PCR, which allows the amp-
li®cation and analysis of different genes within individual B cells
that were mobilized from a de®nite localization in a certain tissue
environment, such as the skin (Golembowski et al, 2000). For this
study, this technique was chosen to characterize the heavy (VH) and
light (VL) chain variable region genes in eight patients with
PCBCL, four of them suffering from follicle center cell lymphomas
localized on the head and trunk areas, the others with large B cell
lymphomas of the leg. We compare V-gene usage and mutational
pattern between the two subentities of PCBCL on the level of
single tumor B cells. Our data provide evidence for a germinal
center cell origin of PCBCL.
MATERIALS AND METHODS
Patients This study included two groups of patients suffering from
PCBCL. Group I consisted of four patients with follicle center cell
lymphomas with head and trunk localization (Fig 1a), whereas group II
included four patients with large B cell lymphomas of the leg (Fig 1b).
The course of disease differed markedly between the two groups.
Whereas two patients in group II died within 1±1.5 y after diagnosis, all
four patients in group I have a time course of more than 5 y with
repeated treatment, such as surgery, radiation, or immune therapy (not
shown in detail), achieving partial or complete remission. Preliminary
data from patients IL and UK (Table I) were presented elsewhere
(Gellrich et al, 1997; Golembowski et al, 2000). Tissue material from
patients DG and AZL (large B cell lymphoma of the leg) was kindly
provided by Dr M.H. Vermeer and Prof R. Willemze (Amsterdam, the
Netherlands). None of the patients showed internal lymphoma
involvement at the time when biopsies were taken, investigated by
lymph node sonography, computed tomography, and blood and bone
marrow analysis. In all patients the typical histologic picture was found
(Fig 2). In follicle center cell lymphomas of the head and trunk area,
nodular or diffuse in®ltrates with sparing of the epidermis were observed.
The lesions contained a variable mixture of centrocytes and centroblasts
with many in®ltrating reactive T cells. Patients with large B cell
lymphomas of the leg showed a rather monotonous in®ltrate with a
higher proportion of centroblasts, large centrocytes, lymphoblasts,
multilobated cells, and only a few reactive T cells. Immunohistochemical
analysis showed the expression of the B cell marker CD20 on most
in®ltrating cells, and in most cases the expression of the proliferation
marker Mib-1. The overexpression of one particular light chain type
suggests a clonal B cell expansion. Large B cell lymphomas of the leg
differed from follicle center cell lymphomas by positive staining for bcl-2
of the tumor B cells (Table I).
Figure 1. Clinical presentation of cutaneous
B cell lymphoma patients chosen for single
cell analysis. The typical clinical picture of
patient IL with a large B cell lymphoma of the leg
(A) and patient UK with a follicle center cell
lymphoma localized at the head (B) are shown.
Table I. Patient data and immunohistochemical analysis of eight cases of PCBCLa
Patient Age, sex Localization CD20 bcl-2 CD30 Mib-1 CD5 CD10 k l
UK 58, M CBCL-HAT + ± ± 100% ± ± + ±
WS 84, M CBCL-HAT + ± ± 100% ± ± + ±
LB 55, M CBCL-HAT + ± ± 90% ± ± ± +
GG 77, F CBCL-HAT + ± ± 100% ± ± + ±
IL 49, F CBCL-LL + + ± 100% ± ± ± +
VM 75, F CBCL-LL + + ± 100% ± ± + ±
DG 58, F CBCL-LL + + ± ND ± ± ± +
AZL 69, F CBCL-LL + + ± ND ± ± ± ±
aMarker expression was indicated with respect to the proposed tumor cell population. M, male; F, female; CBCL-HT, follicle center cell lymphoma localized in the
head/trunk area; CBCL-LL, large B cell lymphoma of the leg; ND, not determined.
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Micromanipulation Frozen skin sections (10 mm thick) were stained
with an anti-CD20 antibody (Dako Diagnostika, Hamburg, Germany)
using biotinylated Fab-anti-mouse and streptavidin±alkaline phosphatase
complexes (Dako) as developing reagents. Control sections were stained
with anti-CD3 antibodies. Only in patient GG, were the in®ltrate
obviously contained only a few tumor B cells, a k chain staining was
carried out taking into consideration the statistical overexpression of this
light chain. After washing, bound alkaline phosphatase was visualized by
staining with New Fuchsin. The slides were counterstained with
hematoxylin. Single cells were mobilized under the microscope (Nikon,
DuÈsseldorf, Germany) with the help of a hydraulic micromanipulator
(Narishige, Tokyo, Japan) using 600 3 magni®cation. Thereafter, single
cells were aspirated into a micropipette (Narishige), put into 20 ml PCR
buffer supplemented by 1 ng per ml rRNA (both from Boehringer,
Mannheim, Germany) and stored at ±20°C. Photographs were taken
before and after the micromanipulation of each cell.
PCR ampli®cation of VHDJH and VLJL rearrangements A
seminested PCR approach was applied to amplify simultaneously the
immunoglobulin heavy and light chain gene rearrangements of isolated
single B lymphocytes. To this end, sets of family-speci®c primers for the
framework region (FR) I of the variable VH, Vk, and Vl genes were
used together with two sets of nested primers binding to the joining (J)
region of each locus. All primers were synthesized according to KuÈppers
et al (1993, 1995, 1997) and BraÈuninger et al (1999). Before PCR, the
single cells were incubated with 0.25 mg per ml proteinase K
(Boehringer Mannheim) for 55 min at 50°C, and additionally at 95°C
for 10 min (enzyme inactivation). The reaction mix (50 ml) for the ®rst
round of ampli®cation contained: PCR buffer, 2.5 mM MgCl2, 200 mM
of each deoxyribonucleoside triphosphate, 7 nM of each primer, and
3.5 U Expand High Fidelity Taq-polymerase (all chemicals from
Boehringer Mannheim). PCR ampli®cation was carried out on a
Personal Cycler (Biometra, GoÈttingen, Germany): one cycle at 95°C for
2 min, 65°C for 1 min (when Taq polymerase was added), 72°C
for 1 min, followed by 35 cycles at 95°C for 30 s, 59°C for 30 s, 72°C
for 1 min, and ®nal extension at 72°C for 5 min. Further ampli®cation
of IgH and Igk genes was performed as previously described (Gellrich et
al, 1997; Golembowski et al, 2000). For ampli®cation of the l-chain
rearrangement, aliquots of the ®rst round were reampli®ed using only
one of the Vl-speci®c primers plus a set of more internally binding Jl
primers in separate reactions for each Vl gene family. The reaction mix
(50 ml) for the second round of ampli®cation contained 1 ml of the
ampli®cation product from the ®rst round, PCR buffer, 1.5 (IgH) or
2.5 mM (IgkH/Igl) MgCl2, 200 mM of each deoxyribonucleoside
triphosphate, 7 nM (IgH) or 50 nM (Igk/Igl) of each primer, and 5 U
(IgH) or 1.25 U (Igk/Igl) Taq-polymerase (all Perkin Elmer). The
second round cycle program was carried out on a TRIO-Thermoblock
(Biometra) and consisted of one cycle at 95°C for 2 min, 68°C for
5 min (addition of Taq polymerase), 72°C for 1 min, 45 cycles at 95°C
for 1 min, 61°C (VH1, VH2, VH5, VH6, Vk, Vl) or 65°C (VH3, VH4)
for 30 s, 72°C for 1 min, and a ®nal extension at 72°C for 5 min. A
5 ml aliquot of the reaction mixture was analyzed on a 2% agarose gel.
Strong attention was paid to avoid any contamination with DNA. The
micromanipulation as well as the ®rst and second round of PCR were
carried out separately in different rooms. As negative controls, T cells
picked from CD3-stained adjacent sections were used during the same
experiment. PCR products were puri®ed with the QIAquick PCR
Puri®cation Kit (Qiagen, Hilden, Germany), and used for direct
sequencing (see below).
Cloning of the germline equivalent of the VH gene rearranged in
the lymphoma B cells In order to exclude an allelic polymorphism
for subsequent mutational analysis, the patient's speci®c germline VH
gene rearranged in the lymphoma B cells was cloned and sequenced
in three cases (patients UK, LB, and IL). To this end, genomic DNA
was required. We used paraf®n-embedded skin tissue, which was ®rst
depara®nized and then treated with proteinase K. Primers were designed
to amplify the proposed germline genes, one annealing to the leader
sequence of the respective VH gene family, VH5 for patient UK (5¢-
CCC CTG ATT CAA ATT TTG TGT CTC C-3¢); VH4 for patient
LB (5¢-TGG TGG CRG CTC CCA GAT GTG A-3¢), and VH3 for
patient IL (5¢-CTA GGA AGA TTG AGT GTG TGT GGA T-3¢), and
the second primer speci®c for the respective recombination
signal sequence (5¢-CTC GGG GCT GGT TTC TCT CAC TGT G-3¢
(patient UK), 5¢-GGG CTC ACA CTC ACC TCC CCT CAC T-5¢
(patient LB), and 5¢-CTC ACA CTG ACT TCC CCT CAC TGT G-3¢
(patient IL). The PCR products were puri®ed with the QIAquick Gel
Extraction Kit (Qiagen) and then cloned using the TA-Cloning Kit
(Invitrogen, Leek, Netherlands) according to the manufacturer's protocols,
and ®nally sequenced (see below).
Reverse transcription±PCR ampli®cation and analysis of the VH
gene transcript To analyze the lymphoma cell-speci®c sequence on
the transcriptional level, mRNA was isolated from cryopreserved tissue
of patients UK and LB using the Oligotex Direct mRNA-Kit (Qiagen).
Then, cDNA was prepared with the Superscript Preampli®cation System
(Gibco BRL, Eggenstein, Germany). For PCR ampli®cation the
following primer pairs were used: 5¢ the respective family speci®c VH
primer (see section single cell PCR), and 3¢ a primer speci®c for the
CH1 domain of one of the human immunoglobulin isotypes (cm: 5¢-
CCA AGC TTA GAC GAG GGG GAA AAG GGT T-3¢; Cg: 5¢-
CAC AAG CTT GAA GTA GTC CTT GAC CAG GC-3¢; Cd: 5¢-
Figure 2. Histology of cutaneous B cell lymphomas. (1) follicle
center cell lymphoma localized at the head; (2) large B cell lymphoma.
(A) HE stain; (B) CD20; (C) GIEMSA; (D) bcl-2. Scale bar: (A, B)
50 mm; (C, D) 200 mm.
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TGG CCA GCG GAA GAT CTC CTT CTT-3¢; Ca: 5¢-CCC GGA
GGC ATC CTG GCT GGG-3¢; Ce: 5¢-GGG TCG ACA GTC ACG
GAG GTG GCA TT-3¢). The PCR products were puri®ed with the
QIAquick Gel Extraction Kit (Qiagen) and then cloned using the TA-
Cloning Kit (Invitrogen), again according to the manufacturer's
protocols. Five (UK) and eight (LB) clones were sequenced.
Gene sequence analysis DNA sequencing was performed with the
Dye Terminator Cycle Sequencing Ready Reaction Kit (Perkin Elmer)
on a Sequencing System 373 (Applied Biosystems, Weiterstadt,
Germany). Ampli®cates from single cell PCR were used for direct
sequencing. To this end, the respective V gene family speci®c primer,
used in the second round PCR, was applied to the sequencing reaction.
Once the rearranged J segment became obvious, the respective internal
J-speci®c primer was used to verify sequence information. For plasmid
sequencing, the primers T7 (5¢-AAT ACG ACT CAC TAT AGG
GCG-3¢) and M13r (5¢-TTC ACA CAG GAA ACA GCT ATG ACC-
3¢) were used. All sequences were analyzed online using the Software
``DNAPLOT'' (created by H.-H. Althaus, University of Cologne,
Germany) and compared with the gene bank ``IMGT, the international
ImMunoGeneTics database'' (Lefranc, 1997) (http://imgt.cines.fr:8104;
initiator and coordinator: Marie-Paule Lefranc, Montpellier, France) for
determining the most similar germline VH/VL genes.
RESULTS
VHDJH and VLJL rearrangements in single B cells A total of
532 single B cells was isolated by micromanipulation from skin
biopsies of eight PCBCL patients. Applying a single cell PCR
approach, clonally related immunoglobulin heavy chain gene
rearrangements (VHDJH) were obtained in three of four follicle
center cell lymphomas, and three of four large B cell lymphomas of
the leg. (All sequences were submitted to EMBL/GenBank
database. Accession numbers: IGHV5-51UK±Y12817;
UKVH5A±Y11556; UKVH5B±Y11557; LBVH4A±AJ292947;
LBVH4B±AJ292948; LBVH4C±AJ292949; GGVH1±AJ292938;
ILVH3±Y10020; VMVH3A±AJ292939; VMVH3B±AJ292940;
DGVH6A±AJ292941; DGVH6B±AJ292942; DGVH6C±
AJ292943; DGVH6D±AJ292944; DGVH6E±AJ292945;
DGVH6F±AJ292946; UKVK3A±AJ223760; UKVK3B±
AJ223761; WSVK3A±AJ292955; WSVK3B±AJ292956;
WSVK3C±AJ292957; WSVK3D±AJ292958; LBVL3A±AJ292950;
LBVL3B±AJ292951; LBVL3C±AJ292952; LBVL3D±AJ292953;
LBVL3E±AJ292954; GGVK3±AJ292937; VMVK3±AJ292936;
DGVL2A±AJ292934; DGVL2B±AJ292935; AZLVK1A±
AJ292931; AZLVK1B±AJ292932; AZLVK1C±AJ292933.)
Ampli®cation failed in patients WS and AZL, whereas light chain
gene rearrangements could be obtained in these cases. From patient
IL (large B cell lymphoma of the leg), we were not able to amplify a
clonal light chain gene rearrangement (Table II). Possible reasons
for failure of ampli®cation include somatic point mutations at sites
of primer annealing or some kind of selective DNA degradation.
The latter is rather unlikely, regarding the successful ampli®cation
of light chain rearrangements in case of failure of heavy chain
ampli®cation and vice versa but cannot be ruled out because of the
localization of the immunoglobulin loci on different chromosomes.
Depending on the patient, clonal VHDJH genes could be
detected in 25±50%, and clonal VLJL genes were seen in 9±44% of
the isolated cells (Table II). We never found biallelic rearrange-
ments within the clonally expanded B cell population. In T cells
isolated as negative controls, we never saw an immunoglobulin
gene rearrangement.
The experimental design focused on obtaining the immunoglo-
bulin gene sequences of the clonally expanded B cells. With the
clonal rearrangements becoming obvious during evaluation of ®rst
sequence data, we went on analyzing only those PCR products that
had been ampli®ed with the corresponding V gene family speci®c
primer annealing to clone-speci®c variable region genes. PCR
products derived from single cells with other primer pairs were
either not sequenced or not analyzed in detail throughout these
studies. Therefore, we do not conclude from our data the
proportion of nonclonal B cells within the in®ltrate, and to
Table II. Clonal immunoglobulin heavy and light chain gene rearrangements detected by single cell PCR in skin sections
of PCBCL patients
Patient
No. of cells
analyzed Clonal IgH rearrangement
No. of clonal
IgH sequencesa
Clonal IgL
rearrangement
(VLJL)
No. of clonal IgL
sequencesa
No. of cells with both
clonal IgH and IgL
sequences(VHDJH)
UK 129 IGHV5±51UK±D6-13±JH5b 19 (UKVH5A)
13 (UKVH5B)
IGKV3-20*1±JK2 6 (UKVK3A)
5 (UKVK3B)
4
WS 100 ± ± IGKV3-20*1±JK2 3 (WSVK3A)
5 (WSVK3B)
12 (WSVK3C)
4 (WSVK3D)
±
LB 126 IGHV4-59*3±D7-27±JH4 44 (LBVH4A)
1 (LBVH4B)
1 (LBVH4C)
IGLV3-21*2±JL2/JL3 28 (LBVL3A)
1 (LBVL3B)
1 (LBVL3C)
3 (LBVL3D)
1 (LBVL3E)
24
GG 18 IGHV1-69*1±D3-22±JH4 8 IGKV3-20*1±JK2 8 6
IL 45 IGHV3-7*1±D?±JH3a 14 ± ± ±
VM 42 IGHV3-74*1±D1-26±JH4 21 (VMVH3A)
1 (VMVH3B)
IGKV3-20*1±JK2 13 11
DG 36 IGHV6-1*1±D6-25±JH4 9 (DGVH6A)
1 (DGVH6B)
1 (DGVH6C)
1 (DGVH6D)
1 (DGVH6E)
1 (DGVH6F)
IGLV2-8*1±JL1 8 (DGVL2A)
1 (DGVL2B)
6
AZL 36 ± ± IGKV1-5*3±JK3 13 (AZLVK1A)
1 (AZLVK1B)
1 (AZLVK1C)
±
aNumbers of clonal IgH and IgL gene sequences are indicated separately for each of the identi®ed subclones. IgH, immunoglobulin heavy chain; IgL, immunoglobulin
light chain. Immunoglobulin gene nomenclature according to Lefranc (1997); for VH genes see Pallares et al (1999); for VK genes see Barbie and Lefranc (1998); for VL
genes see Pallares et al (1998).
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speculate about the immunoglobulin gene repertoire expressed in
this cell population.
Within the clonal immunoglobulin heavy chain rearrangements,
members of ®ve VH gene families (no VH2, VH7 genes) were
found, twice a VH3 gene was detected. Four of six rearrangements
contained a JH4 gene, the others JH5b and JH3a genes, respectively.
Five times a D gene segment could be identi®ed. The CDR3
region of patient IL, however, did not show signi®cant homology
to any published D gene sequence when using the IMGT,
international ImMunoGeneTics database (Lefranc et al, 1997) for
alignment. The length of the heavy chain CDR3 segments varied
from 9 to 15 amino acid residues. In all cases, N-nucleotide
insertion was observed, taking place mostly at both the VHD and
DJH junctions (Fig 3).
In ®ve patients, the lymphoma B cells contained clonal VkJk
gene rearrangements. In three of four follicle center cell lymphomas
and in one large B cell lymphoma of the leg, the IGVK3-20*1 Vk
gene element (Lefranc, 1997; Barbie and Lefranc, 1998) was used
for recombination. From clonal B cells of two patients, we
ampli®ed l light chain rearrangements. The IGLV3-21*2 (patient
LB, group I) and IGLV2-8*1 (patient DG, group II) Vl gene
segments (Lefranc, 1997; Pallares et al, 1999) were recombined in
these cases. In ®ve of eight patients we succeeded in detecting an
immunoglobulin heavy and a light chain gene rearrangement
simultaneously within the same isolated B cell (Table II).
Mutational analysis of VH and VL genes All VH and VL
gene segments detected in clonal B cells of PCBCL carried a
high load of somatic point mutations, suggesting from sequence
comparison with the most closely related germline VH/VL genes
(Table III and amino acid sequences in Figs 3 and 4). From
patients UK (VH5), LB (VH4), and IL (VH3), the individual
heavy chain V region germline genes IGHV5-51UK (Gellrich et
al, 1997), IGHV4-59*3, and IGHV3-7*1 (Lefranc, 1997;
Pallares et al, 1999) were cloned and used for further
sequence analysis. The mutation rate (calculated as the ratio
of nucleotide exchanges per rearranged V gene) was in the
range of 9.2 and 16.3% for the heavy chain (VH), and 5.4 and
15.5% for the light chain (VL). No differences were observed
when comparing the number of mutations in follicle center cell
lymphomas and large B cell lymphomas of the leg.
Replacement mutations, resulting in an exchange of amino acid
residues, were found to be distributed across the whole VH/VL
Figure 3. Amino acid sequences of the
variable regions of immunoglobulin heavy
chains expressed in PCBCL. Amino acid
exchanges in comparison with the respective
germline gene are indicated by bold letters.
Replacement mutations underlaid in gray
represent common exchanges found in more than
one tumor patient. Identi®ed D-gene segments
are underlined. Sequences of identi®ed subclones
are named using capital letters after the number of
the rearranged V gene family. Indication of the
location of CDR and FR stretches, and position
numbering are given.
Table III. Analysis of VH and VL gene mutations of clonal immunoglobulin rearrangements in PCBCL patients
a
Patient
Immunoglobulin heavy chain Immunoglobulin light chain
No. of
mutations
% of
homology
FR/
CDR
Observed Expected
R/Sa
No. of
mutations
% of
homology
FR/
CDR
Observed Expected
R/Sa
R S R/S R S R/S
UK 22 90.8 FR
CDR
9
8
3
2
3.0
4.0
3.4
3.6
14 94.6 FR
CDR
1
6
5
2
0.2
3.0
3.1
3.4
WS ± ± FR
CDR
±
±
±
±
±
±
±
±
14 94.6 FR
CDR
0
7
3
4
0
1.8
3.1
3.4
LB 29 86.6 FR
CDR
10
9
6
4
1.6
2.3
2.7
4.6
27 89.4 FR
CDR
10
10
6
1
1.7
10.0
2.9
4.3
GG 34 83.8 FR
CDR
8
11
12
3
0.7
3.7
3.2
3.5
36 84.5 FR
CDR
6
15
7
8
0.9
1.9
3.3
3.4
IL 36 83.7 FR
CDR
12
10
12
2
1.0
5.0
3.1
4.9
± ± FR
CDR
±
±
±
±
±
±
±
±
VM 23 88.9 FR
CDR
5
9
7
2
0.7
4.5
3.1
4.5
16 93.3 FR
CDR
5
6
1
4
5.0
1.5
3.2
3.4
DG 29 86.4 FR
CDR
8
15
5
1
1.6
15.0
2.9
4.1
18 92.7 FR
CDR
7
7
2
2
3.5
3.5
3.1
3.1
AZL ± ± FR
CDR
±
±
±
±
±
±
±
±
28 89.1 FR
CDR
5
10
8
5
0.6
2.0
3.0
4.3
aR, replacement; S, silent; FR, framework region; CDR, complementarity determining region. Calculation according to Chang and Casali (1994).
1516 GELLRICH ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
gene segment with a slight predominance of CDR over FR gene
stretches (Figs 3 and 4).
When comparing the clonal VH genes of different patients, a few
common replacement mutations become obvious (for details see
Fig 3). These amino acid exchanges are located within the CDR1,
CDR2, and FR3 regions, obviously independent of the rearranged
VH gene family and independent of the belonging to one of the
patient groups. They took place in at least two, and in one case
affected three VH genes (UKVH5, ILVH3, VMVH3; at position 31
(CDR1); S±N exchange). The same observation was made for the
light chain, where common exchanges were found within the
CDR1, CDR2 and FR2 region even when comparing k and l
rearrangements or across patient groups (for details see Fig 4).
Again, in one case three rearrangements are affected within the
CDR1 region showing a S±N exchange (LBVl3, GGVk3,
AZLVk1).
A calculation of the ratio of observed replacement (R) vs silent
(S) mutations compared with the respective values for a
nonselected, by chance mutation of the individual germline V
region gene according to Chang and Casali (1994), is provided in
Table III. These calculations were done only for the predominant
clonal heavy and light chain sequence in each patient, subclones
were not included (see below). When R/S analysis was performed
for the tumor-related heavy chain V segments, in two of three
follicle center cell lymphomas and in three of three large B cell
lymphomas of the leg the R/S ratio for the CDR stretches was
slightly or much higher than expected. More interestingly, in all
clones, except for patient UK (follicle center cell lymphoma), the
FR gene segments were signi®cantly less altered by replacement
mutations, resulting in a lower observed R/S ratio than statistically
expected. The same calculation was done for the light chain. Here,
R/S ratios for the CDR vary from much lower to signi®cantly
higher observed vs expected values, equally distributed between
both groups of patients. Regarding the light chain FR, four of four
follicle center cell lymphomas show a clear counter selection against
replacement mutations, resulting in R/S ratios far below the
expected values. Among large B cell lymphomas of the leg only
once a comparable counter selection was seen, for the other two
patients more replacement mutations than statistically expected
were observed. Summarizing, the R/S ratio calculations indicate an
antigen-driven selection of the transformed B cells in all patients
with fewer replacement vs silent mutations in the FR regions, and
higher ratios than statistically expected within the CDR in most
cases. Again, the distribution pattern of mutations is comparable in
both subentities of PCBCL.
Detection of tumor cell-speci®c VH gene transcripts in
biopsy mRNA From cryopreserved material of two patients we
were able to prepare mRNA/cDNA. Using a 5¢ VH family speci®c
oligo in combination with a 3¢ oligo speci®cally binding to one
of the different immunoglobulin isotypes CH1 regions, we
determined the immunoglobulin isotype produced by the
lymphoma cells in patients UK and LB. In patient UK, the
lymphoma cell-speci®c VHDJH rearrangement was ampli®ed as a
cm-transcript. This was veri®ed by the sequencing of ®ve plasmids
that contained identical VHDJH rearrangements previously found in
single tumor B cells. In patient LB, the clone-speci®c VHDJH genes
were sequenced identically in eight plasmids cloned from a PCR
product obtained with the cm-CH1-primer, and are therefore
suggested to be transcribed in context with a cm gene. In this
patient, however, a faint PCR band indicated a Cd-transcript as
well but we were unable either to clone and sequence this
transcript or to obtain the tumor-speci®c VHDJH rearrangement by
using a CDR3-speci®c 3¢ primer (not shown in detail).
Intraclonal diversity ± clonal evolution of tumor cells in
PCBCL In six of eight patients, we ampli®ed single clonally
related heavy or light chain gene rearrangements with a slightly
different mutational pattern in comparison with the dominant
clonal sequence (Figs 3 and 4). This observation was made for the
heavy chain in patients LB and UK (follicle center cell lymphomas)
and patients VM and DG (large B cell lymphomas of the leg), and
for the light chain in patients DG, AZL (large B cell lymphoma of
the leg), and patients UK, WS, and LB (follicle center cell
lymphomas). In all patients an identical immunoglobulin gene
sequence was found in the vast majority of the analyzed cells. Only
a few single cells per biopsy were detected carrying
immunoglobulin genes with a slightly differing mutational
pattern. As an example, in 21 cells from patient VM the
dominant clone VMVH3A was found (Table III). In one
additional B cell, however, the gene sequence (VMVH3B)
differed in a single nucleotide leading to an amino acid exchange
R±H instead of R±Q at position 50 within the CDR2 compared
with the germline sequence. In patient DG, sequence DGVH6A
was seen in nine cells, whereas of another ®ve individual B cells,
while belonging to the tumor clone, each showed a slight
intraclonal diversity (DGVH6B±F). These variations consisted of
only one or two nucleotide exchanges per cell compared with the
dominant clonal sequence. Interestingly, an additional replacement
mutation was shared by two of these cells (DGVH6B, DGVH6C)
and led to an R±M exchange at position 38 within FR2, one of
them carrying a further silent mutation in FR3. Two other cells
Figure 4. Amino acid sequences of the
variable regions of immunoglobulin light
chains expressed in PCBCL. Amino acid
exchanges in comparison with the respective
germline gene are indicated by bold letters.
Replacement mutations underlaid in gray
represent common exchanges found in more than
one tumor patient. Sequences of identi®ed
subclones are named using capital letters after the
number of the rearranged V gene family.
Identi®ed D-gene segments are underlined.
Indication of the location of CDR and FR
stretches, and position numbering are given.
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differed from DGVH6A in an individual replacement mutation
within the CDR2 (V±R at position 61 (DGVH6D) or V±M at
position 63 (DGVH6F), respectively, with the latter harboring an
additional silent mutation within the J segment. Yet another cell
carried a further silent mutation within the CDR1 region at
position 31a (DGVH6E). Regarding the patients' l light chain
variable segment DGVL2, again one cell (DGVH6B) contained an
additional replacement in position 29 (CDR1). As these sequence
variants were found in single cells only, however, we decided not
to include the respective rearrangement into statistical calculations.
DISCUSSION
In this study, a comparative analysis of the immunoglobulin heavy
and light chain variable region genes of individual tumor B cells
was performed in two subentities of PCBCL. Four patients
suffering from follicle center cell lymphomas of the head and
truck areas and four patients with large B cell lymphomas of the leg
were included. The aim was to investigate the maturational status of
the malignant B cell population and to de®ne possible differences in
the level of immunoglobulin encoding genes with respect to the
observed distinct clinical behavior of these clinically and histolo-
gically de®ned subtypes of PCBCL.
The identi®cation of the immunoglobulin gene rearrangement
of the malignant B cell population from crude DNA obtained from
a tissue section may be complicated due to a possible under-
representation of clonally related lymphoma cells or an ampli®ca-
tion of genes with different ef®ciencies resulting in an over-
representation/under-representation in gene libraries. Further-
more, the problems of PCR-induced nucleotide exchanges and
the formation of hybrid artifacts (Ford et al, 1994), generally seen in
analyses of cell populations, need to be addressed as they may
interfere with accurate mutational analysis and the detection of
intraclonal diversity. Therefore, we applied a technique of
micromanipulation of single B lymphocytes from skin sections
followed by single cell PCR (Gellrich et al, 1997) and direct
sequencing, which is capable of overcoming these problems
(KuÈppers et al, 1997).
Analyzing 532 single B lymphocytes from skin tissue samples, we
obtained clonal VHDJH rearrangements in six of eight patients, and
clonal VLJL gene rearrangements in seven of eight patients.
In accordance with ®ndings in nodal follicular lymphomas
(Bahler et al, 1991), lymphoplasmacytoid lymphomas or large B cell
lymphomas (Rosenquist et al, 1999), we saw an unbiased usage of
different members of ®ve of seven VH gene families. Regarding the
light chain, we detected the usage of the Vk germline gene
IGKV3-20*1 (Lefranc, 1997; Barbie and Lefranc, 1998) in four of
seven lymphomas, in which we were able to amplify a light chain
rearrangement. One cannot, however, conclude a biased usage of
this individual germline gene in PCBCL patients. First, the number
of patients studied is too small, and secondly, this Vk segment,
corresponding to the A27 gene (nomenclature according to
Straubinger et al, 1988), was found to be the most often rearranged
Vk germline gene, at a rate of 14%, in the productive repertoire of
IgM + B cells (Foster et al, 1997). Analysis of the human cord
blood (Feeney et al, 1997) and peripheral blood (Cox et al, 1994)
Vk repertoire showed a comparable picture.
Interestingly, we never detected any biallelic immunoglobulin
gene rearrangements, one of which could be nonproductive, in the
single tumor cells. All ampli®ed VHDJH or VLJL rearrangements
were found to be potentially productive as they contain no stop
codons. This cannot be explained to be in¯uenced by the
experimental approach. Applying this method to the analysis of
B cells in skin lesions of a pleomorphic cutaneous T cell lymphoma,
we could detect biallelic rearrangements (Golembowski et al, 1999)
in a comparable fraction of cells as other groups did in both normal
(Brezinschek et al, 1995; Dorner et al, 1997) and malignant B cells
(BraÈuninger et al, 1999). To answer the question on the occurrence
of more than one rearrangement per B lymphocyte, the single cell
technique is the only acceptable approach. Considering the
hypothesis that the multiple molecular processes during B cell
expansion and differentiation that involve DNA strand breaks,
namely, class switching, hypermutation, and gene rearrangement,
may contribute to a certain chromosomal instability in B cells,
failures in control mechanisms of theses processes can be responsible
for B cell tumor genesis through the generation of chromosomal
translocations into immunoglobulin loci (KuÈppers et al, 1999). The
fact that we found only one VH and VL rearrangement per B cell
clone in our PCBCL patients could be interpreted to re¯ect a lower
molecular instability in comparison with other B cell malignancies.
This, however, cannot explain the differences in clinical behavior
between large B cell lymphomas of the leg and follicle center cell
lymphomas. In this respect, other mechanisms may play a part, such
as bcl-2 expression (Geelen et al, 1998), which was found in four of
four patients with large B cell lymphoma of the leg in this study.
The main aim of our experiments was a mutational analysis of
immunoglobulin genes in single lymphoma B cells. We found all
tumor B cell derived VH and VL gene segments to be extensively
altered by somatic point mutations when compared with the
published germline counterparts (Lefranc et al, 1999). Mutation
frequencies, which did not differ between the two subentities of
PCBCL, ranged from 9.2 to 16.3% for the heavy chain (VH), and
from 5.4 to 15.5% for the light chain (VL). These frequencies are
signi®cantly higher than reported for VH genes of normal germinal
center or memory B cells for which mutation rates of up to 3%
were found (Pascual et al, 1994; Tomlinson et al, 1996). The
observed distribution of replacement vs silent mutations over both
CDR and FR gene segments was compared with the statistically
expected R/S ratios according to Chang and Casali (1994). These
data (see Table III) are suggestive of a selection for the expression
of functional antigen receptors by those B cells that gave rise to the
lymphoma process. This view is supported by the apparent counter
selection against replacements within the FR regions in most VH
and VL gene segments. The FR regions are essential for the
preservation of the antibody structure as a prerequisite for the
expression of a functional antigen receptor, which in turn usually is
important for cells surviving due to signals obtained from the result
of antigen binding. One cannot distinguish, however, from the
mutational pattern whether the process of lymphoma genesis is
antigen driven by itself or whether antigen selection took place
during the phase of a physiologic germinal center reaction prior to
the putative point of transformation. Furthermore, it is dif®cult to
discuss the statistical calculations of the mutational pattern in
concern with antigen binding capacity, as one single mutation may
be able to contribute signi®cantly to af®nity maturation and even to
speci®city changes (Rudikoff et al, 1982; Bruggemann et al, 1986).
We found intraclonal diversity in six of eight PCBCL patients
(three large B cell lymphomas of the leg and three follicle center
cell lymphomas). In four patients (two large B cell lymphomas of
the leg and two follicle center cell lymphoma), the heavy chain
rearrangement exhibited intraclonal diversity, in ®ve patients (three
follicular center cell lymphomas and two large B cell lymphomas of
the leg) the light chain showed some sequence variations. In most
cases, these differences resulted from replacement mutations within
the CDR indicating a process of ongoing mutation. Degree and
distribution of intraclonal diversity between VH and VL genes were
comparable. Although one should interpret these data with caution,
especially regarding the conclusion about ongoing mutation, the
single cell PCR technique seems to be the only method to
discriminate accurately between different B cell subclones, because
sequence errors can almost fully be excluded (KuÈppers et al, 1997).
The degree of intraclonal diversity detected in our patients seems to
be lower than described by Aarts et al (1998), in patients with
PCBCL, mainly of the immunocytoma subentity. When studying
intraclonal diversity, the disadvantage of the single cell approach
may be that only a minute part of a biopsy can be analyzed. Even if
numerous cells of different sections are isolated, the data obtained
may not necessarily be representative of the whole tumor. Only
when studying sequential biopsies, as in patient UK with the single
cell technique (Golembowski et al, 2000), we were able to show
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clonal evolution due to intraclonal diversity and ongoing mutation.
Summarizing our data and the results published by Aarts et al
(1998), one may state that the subclones in PCBCL differ less from
each other in comparison with what had been shown for the nodal
counterparts (Bahler and Levy, 1992; Zhu et al, 1994; Ottensmeier
et al, 1998), although the mutation rate is equally high. The latter
was speculated to be the result of a prolonged stay in the germinal
center environment of those B cells, which later on become
transformed (Aarts et al, 1998; Gellrich et al, 1997). Whether this
has something to do with pretransforming genetic events is highly
speculative. Interestingly, there is no difference either in the
mutational pattern nor intraclonal diversity detectable between the
two clinical subentities of PCBCL we examined. Taking into
account the recent publication by Matolcsy et al (1999) who
demonstrated that in follicular lymphomas a high intraclonal
diversity due to ongoing mutation appears in association with
transformation from low- to high-grade lymphomas, one may
speculate that the low degree of intraclonal diversity in PCBCL is a
favorable prognostic marker for clinical outcome.
For two lymphoma clones we could demonstrate that they most
likely produce IgM antibodies. This is in accordance with results by
Aarts et al (1998), who found two of four follicle center cell
lymphomas to express IgM (one together with IgD) transcripts,
whereas two showed a class switch to IgG.
In summary, our data from the analysis of VH and VL genes of
single tumor cells in patients with PCBCL indicate a germinal
center cell origin of the malignant B cell population, as seen in most
systemic non-Hodgkin B cell lymphomas (for review see MuÈller-
Hermelink and Greiner, 1998; KuÈppers et al, 1999; Spencer and
Dunn-Walters, 1999). Moreover, all parameters analyzed through-
out these studies, such as VH/VL gene usage, CDR3 length,
mutational pattern, or intraclonal diversity were comparable in the
two subentities of PCBCL we studied. Therefore, the genetically
background of immunoglobulin production does not provide clues
to the different clinical behavior with respect to a much more
aggressive disease progression with early internal involvement in
patients with large B cell lymphomas of the leg (Vermeer et al,
1996). Other mechanisms, such as the role of bcl-2 expression
(Geelen et al, 1998), must be studied to understand these clinically
very important differences. Recently, distinct types of diffuse large
B cell lymphomas have been identi®ed by gene expression pro®ling
(Alizadeh et al, 2000). From these studies it became clear that a large
number of genes differentially expressed during B cell ontogeny
must be responsible for the clinical heterogeneity of B cell
malignancies, which cannot be explained by morphologic diagnosis
even when supplemented with immunohistochemistry.
The ®nding that in all patients the lymphoma B cells contained
potentially productive immunoglobulin gene rearrangements,
resulting most likely in the expression of an intact immunoglobulin
molecule, implies tumor genesis under the in¯uence of the B cell
antigen receptor. Antigen-driven B cell selection and clonal
expansion documented by the typical mutational pattern and
ongoing mutation are characteristic features for extracutaneous
lymphomas such as maltomas. A similar picture can be seen in
PCBCL, although ongoing mutation is detected to a lesser extent,
at least in our patients. Helicobacter pylori, the causative agent of
gastritis, was de®ned as a promiscuity antigen stimulating the B cell
outgrowth in mucosa associated lymphoid tissue (MALT) lym-
phomas (Wotherspoon et al, 1991; Hussel et al, 1993). Clinical
evidence for this phenomenon comes from successful curing of
small cell MALT lymphomas by antibiotic eradication of
Helicobacter pylori (Wotherspoon et al, 1993). This is in interesting
analogy to PCBCL cases, which were cured ef®ciently by
antibiotics for an active accompanying Borrelia burgdorferi infection
(Kutting et al, 1997; Roggero et al, 2000).
The ®nding of lymphoma B cells selected for expression of intact
immunoglobulin molecules motivates the search for causative
agents stimulating malignant B cell outgrowth. These may be of
endogenous (autoimmune) or exogenous (infectious) origin. The
skin as a place of preferential antigen±immune cell interaction may
be an ideal model to provide further insight into lymphoma genesis
and to de®ne new treatment modalities for patients.
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